Phase 2 Study of Preoperative Chemotherapy With Abraxane and Gemcitabine Followed by Chemoradiation for Borderline Resectable or Node-Positive Pancreatic Cancer
Phase of Trial: Phase II
Latest Information Update: 17 Nov 2017
At a glance
- Drugs Fluorouracil (Primary) ; Gemcitabine (Primary) ; Paclitaxel (Primary)
- Indications Adenocarcinoma; Pancreatic cancer
- Focus Therapeutic Use
- 09 Nov 2017 Planned number of patients changed from 46 to 44.
- 09 Nov 2017 Planned End Date changed from 1 Jan 2019 to 1 Jun 2019.
- 10 Jun 2017 Biomarkers information updated